Vitrolife AB/Skr VITR
07:00
08:00
09:00
10:00
11:00
1D1W1MYTD1Y5YMAX
About Vitrolife AB
Vitrolife AB is a biotechnology company that operates in the fertility treatment industry, providing products and services designed to support in vitro fertilization (IVF). The company's portfolio includes culture media, IVF disposable devices, and time-lapse systems for embryo assessment. Founded in 1994, Vitrolife has developed a strong presence in the field of reproductive health by focusing on improving clinical results and patient outcomes. Headquartered in Gothenburg, Sweden, the company serves customers globally, with manufacturing facilities and offices across Europe, the Americas, and Asia. Vitrolife's strategic focus on research and development, along with its commitment to quality and innovation, positions it as a significant player in the global IVF market.
Ticker
Skr VITR
Sector
Primary listing
XSTO
Employees
1,126
Headquarters
Gothenburg, Sweden
Website
Vitrolife AB Metrics
BasicAdvanced
kr 14bn
-
-kr 37.01
1.76
kr 1.10
1.05%
Price and volume
Market cap
kr 14bn
Beta
1.76
52-week high
kr 163.10
52-week low
kr 84.60
Average daily volume
285k
Dividend rate
kr 1.10
Financial strength
Current ratio
3.681
Quick ratio
2.826
Long term debt to equity
19.031
Total debt to equity
19.601
Interest coverage (TTM)
9.10%
Profitability
EBITDA (TTM)
936
Gross margin (TTM)
58.65%
Net profit margin (TTM)
-147.17%
Operating margin (TTM)
16.83%
Effective tax rate (TTM)
-2.35%
Revenue per employee (TTM)
kr 3,020,000
Management effectiveness
Return on assets (TTM)
2.57%
Return on equity (TTM)
-47.27%
Valuation
Price to revenue (TTM)
4.176
Price to book
1.75
Price to tangible book (TTM)
-66.63
Price to free cash flow (TTM)
29.258
Free cash flow yield (TTM)
3.42%
Free cash flow per share (TTM)
3.589
Dividend yield (TTM)
1.05%
Forward dividend yield
1.05%
Growth
Revenue change (TTM)
-5.68%
Earnings per share change (TTM)
-1,108.43%
3-year revenue growth (CAGR)
0.68%
10-year revenue growth (CAGR)
16.38%
3-year earnings per share growth (CAGR)
129.97%
10-year earnings per share growth (CAGR)
35.95%
3-year dividend per share growth (CAGR)
8.97%
10-year dividend per share growth (CAGR)
8.65%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Vitrolife AB stock?
Vitrolife AB (VITR) has a market cap of Skr14B as of May 01, 2026.
What is the P/E ratio for Vitrolife AB stock?
The price to earnings (P/E) ratio for Vitrolife AB (VITR) stock is 0 as of May 01, 2026.
Does Vitrolife AB stock pay dividends?
Yes, the Vitrolife AB (VITR) stock pays dividends to shareholders. As of May 01, 2026, the dividend rate is Skr1.1 and the yield is 1.05%. Vitrolife AB has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Vitrolife AB dividend payment date?
The next Vitrolife AB (VITR) dividend payment is scheduled for May 12, 2026.
What is the beta indicator for Vitrolife AB?
Vitrolife AB (VITR) has a beta rating of 1.76. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.